StockNews.com Begins Coverage on China Pharma (NYSE:CPHI)
by Danessa Lincoln · The Markets DailyStockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report published on Monday. The brokerage issued a hold rating on the stock.
China Pharma Price Performance
Shares of CPHI opened at $0.25 on Monday. China Pharma has a 52 week low of $0.17 and a 52 week high of $1.16. The stock has a 50 day moving average price of $0.22 and a two-hundred day moving average price of $0.26. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.84 and a quick ratio of 0.24.
China Pharma (NYSE:CPHI – Get Free Report) last announced its quarterly earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share (EPS) for the quarter. The company had revenue of $0.93 million for the quarter. China Pharma had a negative return on equity of 60.19% and a negative net margin of 70.47%.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
See Also
- Five stocks we like better than China Pharma
- The Significance of Brokerage Rankings in Stock Selection
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Tesla Stock: Buy the Dips, Sell the Rips